Document - FAVV

More documents

Recommendations

Info

Evaluation of immunoassay kits for determination of ochratoxin A in cerealsTable 23: ReproducibilityCharm SciencesConc (ng/g) Batch N Rec% Mean Rec% CV% SQR CV% Ucomb k=2 (%)5 1 21 100 101 16.0 14.1 28.32 21 114 14.03 21 90 12.0EuroproximaConc (ng/g) Batch N Rec% Mean Rec% CV% SQR CV% Ucomb k=2 (%)2 1 8 95 95 6.9 10.1 22.52 8 95 12.510 1 8 91 91 3.8 4.1 19.82 8 91 4.450 1 8 73 73 9.4 11.3 58.62 8 73 13.0LCTechConc (ng/g) Batch N Rec% Mean Rec% CV% SQR CV% Ucomb k=2 (%)4 1 8 90 105 0.8 1.1 10.32 8 110 0.83 8 115 1.610 1 8 98 96 0.6 0.5 8.12 8 98 0.43 8 92 0.616 1 8 96 96 0.5 0.4 7.52 8 91 0.43 8 101 0.2R-BiopharmConc (ng/g) Batch N Rec% Mean Rec% CV% SQR CV% Ucomb k=2 (%)2 1 3 130 125 9 12 282 4 120 85 1 3 92 105 9 31 322 5 112 113 4 112 264 4 104 107.4 1 3 92 94 4 20 212 5 93 123 4 101 134 4 91 9RomerlabsConc (ng/g) Batch N Rec% Mean Rec% CV% SQR CV% Ucomb k=2 (%)5 1 5 91 93 21.9 17.8 38.72 5 94 12.510 1 5 88 85 8.7 9.3 35.52 5 82 9.830 1 5 80 84 7.7 9.9 38.02 5 87 11.73-28 Administrative evaluation | CODA-CERVA
Evaluation of immunoassay kits for determination of ochratoxin A in cereals3.1.4.7 Cross-reactivityIndicated cross-reactivity for non-targeted components is summarised in Table 24. Only Charm and Romerlabsreport significant false positive results for OTB. Interestingly, cross-reactivity has not been checked for othermycotoxins or non-targets.Table 24: Cross-reactivity in%Manufacturer OTA OTB OTC Otα Cou 4-HC CIT Phe ZEA AFLA B1Aokin NS NS NS NS NS NS NS NS NS NSCharm 100 200 NS NS NS NS NS NS NS NSEuroProxima 100 9.3 NS
Page 1: CODA-CERVAEvaluation of immunoassay
Page 5: We would like to thank the kit manu
Page 8 and 9: 4.1.4.2 Work package II: Cross reac
Page 10 and 11: Table 45: Cross-reactivity in matri
Page 13: 1. Foreword & scope &background
Page 16 and 17: Evaluation of immunoassay kits for
Page 21: Evaluation of immunoassay kits for
Page 27: 3. Administrative evaluation
Page 37 and 38: Measured value (ng/g)Evaluation of
Page 51: 4. Experimental evaluation
Page 60 and 61: ()Evaluation of immunoassay kits fo
Page 62 and 63: Observed Concentration (ng/g)Observ
Page 79: 5. Conclusion and futureprospects

Document - FAVV

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?